Estrogen patches treat prostate cancer

Experts at the Royal College of London (UK) said they had initially tested the solution to bring estrogen into the blood through the skin, opening up a lower cost and safer treatment for prostate cancer paralysis compared to current therapies.

The use of female sex hormones estrogen to treat prostate cancer is a long-used method. Both estrogen and male sex hormones testosterone have very similar chemical properties, so increasing estrogen levels in the body can inhibit the production of testosterone, thereby slowing the growth of cancerous tumors in the front line. paralysis. However, taking the medicine by mouth can make the liver overload, producing chemicals that promote the formation of blood clots, causing heart attacks and strokes. Meanwhile, the LHRHa injection method is often used, although it can control estrogen and testosterone, but it causes side effects like menopausal symptoms in women, leading to bone weakness and risk of diabetes.

Those are the reasons that motivate scientists to study other safer treatments. The main solution is to use patches that function estrogen into the blood through the skin. After comparing the test results between using patch and direct injection on 254 patients, experts found that the patch contained estrogen safely and avoided the menopausal symptoms-like side effects.

Currently, the research team is continuing to try on more than 600 patients to see if this patch works to prevent cancer tumors from developing or not.'This test is an important step towards better and more convenient treatment for prostate cancer patients in the near future,' said Kate Law of the British Cancer Research Foundation.